Siemens Healthineers Redefines Biopsy Workflow With New MAMMOMAT Revelation Mammography System

Siemens Healthineers unveiled MAMMOMAT Revelation,¹ the company’s new premium mammography platform, at the 103^rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 26 to Dec. 1 at Chicago’s McCormick Place,

MAMMOMAT Revelation enables healthcare providers to expand precision medicine, improve clinical outcomes, and increase patient satisfaction. The system’s HD Breast Biopsy solution enables one-click targeting of suspicious areas with a +/- 1mm accuracy. The new integrated specimen imaging tool facilitates immediate control of the biopsy directly at the mammography system. Clinical workflow is improved by eliminating the need for a second imaging system and by reducing patient compression time.

MAMMOMAT Revelation also provides automated breast density measurements at the point of care. Additionally, it expands existing diagnostic options and provides patient access to functional breast imaging with contrast-enhanced mammography.

HD Breast Tomosynthesis with 50-degree scan angle

With its unique 50-degree 3D HD Breast Tomosynthesis, Siemens Healthineers offers the widest scan angle available. This scan angle is the basis for the industry’s highest depth resolution, which provides extremely high-quality 3D images to increase diagnostic confidence and enable earlier detection of even subtle lesions. With MAMMOMAT Revelation, the clinician also can perform biopsies based on 3D HD Breast Tomosynthesis. The HD Breast Biopsy solution enables one-click targeting of suspicious areas with a +/- 1mm accuracy. 

Integrated biopsy specimen imaging tool

Upon acquisition, the tissue sample must be X-rayed to confirm a successful biopsy. In clinical practice today, samples are usually imaged on a second system or on a dedicated specimen scanner, usually in a different room. During this time, the patient remains under compression. MAMMOMAT Revelation can substantially reduce discomfort and anxiety with the InSpect integrated specimen imaging tool. Biopsy samples can be imaged and visualized at the technologist workstation within 20 seconds without radiation exposure to the patient. The system improves the biopsy workflow, shortens patient compression time, and improves the patient experience.

Automated measurement of breast tissue density

Currently, radiologists must estimate breast density visually during the image reading process, which typically occurs after the patient has left the facility. Patients with high breast density at higher risk of developing cancer often require additional workup to rule out breast cancer. Additional imaging procedures require patient callbacks, which can lead to uncertainty and concern.

MAMMOMAT Revelation is the industry’s first mammography platform to provide automated breast density measurements at the point of examination. This information not only enables immediate, personalized risk stratification, but it also allows the facility to provide supplemental imaging while the patient is at the facility. Patients receive results faster, minimizing patient uncertainty and stress. 

Functional breast imaging with Titanium contrast-enhanced mammography

In some cases, purely morphological information from a mammogram or tomosynthesis scan may be insufficient for a precise diagnosis. For example, distinguishing scar tissue from new lesions in a post-surgical examination can be difficult. In addition to purely morphological information, clinicians may require functional information that can be obtained through contrast-enhanced imaging, which is usually performed using breast magnetic resonance imaging (MRI). MAMMOMAT Revelation enables functional imaging directly on the mammography system. Since mammography systems are more widely available than MRI scanners, patient access to more specific breast imaging tools can be improved. And since contrast-enhanced mammography is still not widely utilized, the modular arrangement of MAMMOMAT Revelation enables its expansion to include this and other functionality on an as-needed basis.

Improved patient experience in mammography

Discomfort and pain in addition to related anxiety are key reasons why patients avoid mammography exams. With MAMMOMAT Revelation’s Personalized Soft Compression, the breast compression process is softened and the compression force is automatically and individually adjusted.  Coupled with ergonomic SoftComp Paddles, Personalized Soft Compression enables better breast positioning, more consistent image quality, and reduced patient discomfort.

¹ MAMMOMAT Revelation and Insight BD are 510(k)-pending and are not commercially available in the United States

The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed. Further details are available from the local Siemens Healthineers organizations.

Siemens contact for journalists: Jeff Bell, Siemens Healthineers; Phone: 484-868-8346; E-mail: jeffrey.t.bell@siemens-healthineers.com

Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to achieve better outcomes at lower costs by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.

In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.8 billion and profit of €2.5 billion and has about 48,000 employees worldwide. Further information is available at www.siemens.com/healthineers.